Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I multiple-dose study of FSH-GEX in healthy pituitary-suppressed women
NL-OMON35651Phase 1Active, not recruiting
- Sponsor
- Glycotope
- Start
- Oct 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of follitropin epsilon in infertility (3 arms), sponsored by Glycotope. Primary endpoint: Safety and tolerability of FSH-GEX. Started Oct 2011; status: active, not recruiting.
02
Drugs
follitropin epsilon
03
Conditions
infertility
Beyond the preview
Go deeper on NL-OMON35651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35651.